Kurt F. Somerville’s Gilead Sciences GILD Stock Holding History

Kurt F. Somerville’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,800	Closed	-$466K	–	97
2025 Q4	$466K	Hold	3,800	–	–	0.08%	67
2025 Q3	$422K	Hold	3,800	–	–	0.07%	75
2025 Q2	$421K	Hold	3,800	–	–	0.07%	77
2025 Q1	$426K	Hold	3,800	–	–	0.07%	75
2024 Q4	$351K	Hold	3,800	–	–	0.06%	80
2024 Q3	$319K	Hold	3,800	–	–	0.05%	86
2024 Q2	$261K	Sell	3,800 -5	-0.1%	-$334	0.04%	91
2024 Q1	$279K	Hold	3,805	–	–	0.05%	91
2023 Q4	$308K	Hold	3,805	–	–	0.06%	86
2023 Q3	$285K	Hold	3,805	–	–	0.06%	89
2023 Q2	$293K	Hold	3,805	–	–	0.06%	90
2023 Q1	$316K	Hold	3,805	–	–	0.06%	87
2022 Q4	$327K	Hold	3,805	–	–	0.06%	90
2022 Q3	$235K	Buy	3,805 +5	+0.1%	+$315	0.05%	106
2022 Q2	$235K	Hold	3,800	–	–	0.04%	108
2022 Q1	$226K	Hold	3,800	–	–	0.04%	117
2021 Q4	$276K	Hold	3,800	–	–	0.04%	113
2021 Q3	$265K	Hold	3,800	–	–	0.04%	106
2021 Q2	$262K	Hold	3,800	–	–	0.04%	105
2021 Q1	$246K	Hold	3,800	–	–	0.04%	102
2020 Q4	$221K	Hold	3,800	–	–	0.04%	105
2020 Q3	$240K	Hold	3,800	–	–	0.04%	101
2020 Q2	$292K	Hold	3,800	–	–	0.05%	97
2020 Q1	$284K	Hold	3,800	–	–	0.06%	87
2019 Q4	$247K	Hold	3,800	–	–	0.05%	89
2019 Q3	$241K	Hold	3,800	–	–	0.05%	90
2019 Q2	$257K	Sell	3,800 -1,930	-34%	-$127K	0.05%	90
2019 Q1	$373K	Hold	5,730	–	–	0.07%	83
2018 Q4	$359K	Sell	5,730 -11,469	-67%	-$802K	0.08%	80
2018 Q3	$1.33M	Sell	17,199 -2,395	-12%	-$181K	0.27%	48
2018 Q2	$1.39M	Buy	19,594 +775	+4%	+$54.7K	0.31%	46
2018 Q1	$1.42M	Buy	18,819 +600	+3%	+$47.7K	0.31%	45
2017 Q4	$1.3M	Sell	18,219 -11,898	-40%	-$904K	0.27%	47
2017 Q3	$2.44M	Sell	30,117 -5,135	-15%	-$393K	0.49%	40
2017 Q2	$2.49M	Buy	35,252 +285	+0.8%	+$19K	0.51%	39
2017 Q1	$2.37M	Sell	34,967 -1,378	-4%	-$96.9K	0.5%	41
2016 Q4	$2.6M	Sell	36,345 -14,565	-29%	-$1.08M	0.58%	42
2016 Q3	$4.03M	Buy	50,910 +8,047	+19%	+$654K	0.88%	36
2016 Q2	$3.58M	Buy	42,863 +16,789	+64%	+$1.49M	0.8%	37
2016 Q1	$2.4M	Buy	26,074 +17,353	+199%	+$1.56M	0.55%	44
2015 Q4	$883K	Buy	8,721 +3,121	+56%	+$325K	0.2%	65
2015 Q3	$550K	Hold	5,600	–	–	0.14%	76
2015 Q2	$656K	Hold	5,600	–	–	0.15%	76
2015 Q1	$550K	Sell	5,600 -500	-8%	-$50.8K	0.13%	80
2014 Q4	$575K	Sell	6,100 -200	-3%	-$20.7K	0.14%	80
2014 Q3	$671K	Sell	6,300 -1,550	-20%	-$152K	0.27%	61
2014 Q2	$651K	Sell	7,850 -50	-0.6%	-$3.89K	0.25%	66
2014 Q1	$560K	Sell	7,900 -1,900	-19%	-$149K	0.22%	69
2013 Q4	$736K	Sell	9,800 -3,700	-27%	-$258K	0.28%	64
2013 Q3	$849K	Sell	13,500 -700	-5%	-$41.8K	0.34%	60
2013 Q2	$728K	Buy	+14,200	New	+$740K	0.31%	62

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Kurt F. Somerville's GILD Position: Q1 2026 in Review

Kurt F. Somerville sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 3,800 shares — an estimated $466K sold.

Kurt F. Somerville first reported a position in GILD in Q2 2013 and held it in 51 quarters. The position peaked at $4.03M in Q3 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Kurt F. Somerville reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Kurt F. Somerville sold 3,800 Gilead Sciences shares in Q1 2026, an estimated $466K.
Kurt F. Somerville first reported a position in Gilead Sciences in Q2 2013 and held it in 51 quarters.
Kurt F. Somerville's Gilead Sciences position peaked at $4.03M in Q3 2016.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Kurt F. Somerville's 13F filing for Q1 2026, filed 8 May 2026.